Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication
Emergent BioSolutions' ACAM2000 vaccine approved by FDA for mpox prevention in high-risk individuals, based on safety data and animal study efficacy.
Reference News
Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication
Emergent BioSolutions' ACAM2000 vaccine approved by FDA for mpox prevention in high-risk individuals, based on safety data and animal study efficacy.